How many institutions held CCCC - C4 Therapeutics, Inc. - Common Stock, par value $0.0001 per share in Q1 2021?

83 institutional investors reported CCCC - C4 Therapeutics, Inc. - Common Stock, par value $0.0001 per share for Q1 2021. Use the holders table for investor-level position and value details.

C4 Therapeutics, Inc. - Common Stock, par value $0.0001 per share (CCCC)

Q: What does CUSIP 12529R107 represent in this 13F holders report?

CUSIP 12529R107 is the security identifier for CCCC - C4 Therapeutics, Inc. - Common Stock, par value $0.0001 per share used to aggregate holder disclosures.

CUSIP: 12529R107

Q1 2021 13F Holders as of 31 Mar 2021

Type / Class: Equity / Common Stock, par value $0.0001 per share
Shares outstanding: 88,353,400
Total 13F shares: 25,097,387
Share change: +2,390,297
Total reported value: $926,788,055
Price per share: $36.99
Number of holders: 83
Value change: +$90,401,887
Number of buys: 45
Number of sells: 31

Quarterly Holders Quick Answers

What is CUSIP 12529R107?
CUSIP 12529R107 identifies CCCC - C4 Therapeutics, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2021
Previous quarter: Q4 2020

Recent filing periods for CUSIP 12529R107:

Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024

Top shareholders of CCCC - C4 Therapeutics, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
PERCEPTIVE ADVISORS LLC	13F	Company	3.6%	3,158,566	$104,643,000	—	31 Dec 2020	13F
Cormorant Asset Management, LP	13F	Company	2.8%	2,490,065	$80,021,000	—	31 Dec 2020	13F
RTW INVESTMENTS, LP	13F	Company	2.4%	2,149,228	$68,679,000	—	31 Dec 2020	13F
Bain Capital Life Sciences Investors, LLC	13F	Company	1.9%	1,642,209	$54,406,000	—	31 Dec 2020	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	1.7%	1,530,042	$49,381,000	—	31 Dec 2020	13F
RA CAPITAL MANAGEMENT, L.P.	13F	Company	1.6%	1,377,569	$45,639,000	—	31 Dec 2020	13F
JANUS HENDERSON GROUP PLC	13F	Company	1.5%	1,297,609	$40,370,000	—	31 Dec 2020	13F
BlackRock Finance, Inc.	13F	Company	1.3%	1,139,591	$37,754,000	—	31 Dec 2020	13F
ADAGE CAPITAL PARTNERS GP, L.L.C.	13F	Company	1%	890,498	$29,502,000	—	31 Dec 2020	13F
FMR LLC	13F	Company	0.76%	671,287	$22,240,000	—	31 Dec 2020	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.63%	554,568	$18,373,000	—	31 Dec 2020	13F
Commodore Capital LP	13F	Company	0.54%	481,094	$15,939,000	—	31 Dec 2020	13F
Logos Global Management LP	13F	Company	0.54%	477,928	$15,834,000	—	31 Dec 2020	13F
VANGUARD GROUP INC	13F	Company	0.51%	452,167	$14,980,000	—	31 Dec 2020	13F
SPHERA FUNDS MANAGEMENT LTD.	13F	Company	0.5%	443,824	$14,601,000	—	31 Dec 2020	13F
Invesco Ltd.	13F	Company	0.34%	300,542	$9,957,000	—	31 Dec 2020	13F
Soleus Capital Management, L.P.	13F	Company	0.3%	268,548	$8,897,000	—	31 Dec 2020	13F
ArrowMark Colorado Holdings LLC	13F	Company	0.28%	249,149	$8,254,000	—	31 Dec 2020	13F
Darwin Global Management, Ltd.	13F	Company	0.26%	228,595	$7,573,000	—	31 Dec 2020	13F
EcoR1 Capital, LLC	13F	Company	0.23%	200,000	$6,626,000	—	31 Dec 2020	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.21%	189,251	$6,269,000	—	31 Dec 2020	13F
JENNISON ASSOCIATES LLC	13F	Company	0.2%	173,352	$5,743,000	—	31 Dec 2020	13F
Mizuho Securities Co. Ltd.	13F	Company	0.19%	169,392	$5,612,000	—	31 Dec 2020	13F
Woodline Partners LP	13F	Company	0.19%	166,323	$5,510,000	—	31 Dec 2020	13F
STATE STREET CORP	13F	Company	0.19%	165,131	$5,471,000	—	31 Dec 2020	13F
PICTET ASSET MANAGEMENT LTD	13F	Company	0.19%	163,771	$5,426,000	—	31 Dec 2020	13F
Ikarian Capital, LLC	13F	Company	0.17%	151,500	$5,019,000	—	31 Dec 2020	13F
SUVRETTA CAPITAL MANAGEMENT, LLC	13F	Company	0.16%	143,482	$4,754,000	—	31 Dec 2020	13F
Asymmetry Capital Management, L.P.	13F	Company	0.16%	139,343	$4,616,000	—	31 Dec 2020	13F
NORTHERN TRUST CORP	13F	Company	0.14%	125,070	$4,144,000	—	31 Dec 2020	13F
Maven Securities LTD	13F	Company	0.12%	101,692	$3,655,000	—	31 Dec 2020	13F
ACUTA CAPITAL PARTNERS, LLC	13F	Company	0.12%	110,000	$3,644,000	—	31 Dec 2020	13F
Laurion Capital Management LP	13F	Company	0.12%	109,600	$3,631,000	—	31 Dec 2020	13F
CITADEL ADVISORS LLC	13F	Company	0.12%	103,873	$3,441,000	—	31 Dec 2020	13F
UBS Group AG	13F	Company	0.11%	100,716	$3,336,000	—	31 Dec 2020	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.08%	66,742	$2,212,000	—	31 Dec 2020	13F
Casdin Capital, LLC	13F	Company	0.05%	40,000	$1,325,000	—	31 Dec 2020	13F
Ensign Peak Advisors, Inc	13F	Company	0.05%	40,000	$1,325,000	—	31 Dec 2020	13F
P.A.W. CAPITAL CORP	13F	Company	0.05%	40,000	$1,325,000	—	31 Dec 2020	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.04%	38,527	$1,277,000	—	31 Dec 2020	13F
Bank of New York Mellon Corp	13F	Company	0.03%	28,341	$939,000	—	31 Dec 2020	13F
Nuveen Asset Management, LLC	13F	Company	0.03%	24,624	$816,000	—	31 Dec 2020	13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM	13F	Company	0.02%	21,329	$707,000	—	31 Dec 2020	13F
Affinity Asset Advisors, LLC	13F	Company	0.02%	20,000	$663,000	—	31 Dec 2020	13F
BANQUE PICTET & CIE SA	13F	Company	0.02%	20,000	$663,000	—	31 Dec 2020	13F
Vontobel Holding Ltd.	13F	Company	0.02%	20,000	$663,000	—	31 Dec 2020	13F
Zimmer Partners, LP	13F	Company	0.02%	20,000	$663,000	—	31 Dec 2020	13F
Cubist Systematic Strategies, LLC	13F	Company	0.02%	19,994	$662,000	—	31 Dec 2020	13F
BOOTHBAY FUND MANAGEMENT, LLC	13F	Company	0.02%	16,204	$537,000	—	31 Dec 2020	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.02%	16,140	$535,000	—	31 Dec 2020	13F

Institutional Holders of C4 Therapeutics, Inc. - Common Stock, par value $0.0001 per share (CCCC) as of Q1 2021

As of 31 Mar 2021, C4 Therapeutics, Inc. - Common Stock, par value $0.0001 per share (CCCC) was held by 83 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 25,097,387 shares. The largest 10 holders included PERCEPTIVE ADVISORS LLC, Cormorant Asset Management, LP, RTW INVESTMENTS, LP, PRICE T ROWE ASSOCIATES INC /MD/, Bain Capital Life Sciences Investors, LLC, RA CAPITAL MANAGEMENT, L.P., JANUS HENDERSON GROUP PLC, BlackRock Inc., WASATCH ADVISORS INC, and ADAGE CAPITAL PARTNERS GP, L.L.C.. This page lists 83 institutional shareholders reporting positions in this security for the Q1 2021 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2021 vs Q4 2020 Across Filers

Q4 2020 holders

Q1 2021 holders

Holder diff

Investor	Q4 2020 Shares	Q1 2021 Shares	Share Diff	Share Chg %	Q4 2020 Value $	Q1 2021 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.